Network and cell study links carboplatin to four melanoma targets
Network analysis and B16F0 cell experiments linked carboplatin with CDKN1A, BRCA1, PTEN and AKT1 in melanoma, without establishing clinical benefit.
Tag: CDKN1A
POPULAR NEWS
-
Pilot ultrasound session modestly reduces schizophrenia delusions
-
Network and cell study links carboplatin to four melanoma targets
-
Type 2 diabetes adults favor larger, personal physical activity incentives
-
Brain-computer interface training shows preliminary cognitive and daily-living benefits after stroke